Li Y, Wang X, Li Y, Li W, Liu D, Guo L
Cancer Med. 2025; 14(3):e70650.
PMID: 39912427
PMC: 11800136.
DOI: 10.1002/cam4.70650.
Zhu C, Zhai T, Su M, Pan H, Tang Q, Huang B
Commun Biol. 2024; 7(1):1645.
PMID: 39702756
PMC: 11659476.
DOI: 10.1038/s42003-024-07341-9.
Peng H, Moore C, Saha D, Jiang S, Timmerman R
Front Oncol. 2024; 14:1497351.
PMID: 39687891
PMC: 11647037.
DOI: 10.3389/fonc.2024.1497351.
Li Y, Guo L, Xie P, Liu Y, Li Y, Liu A
BMC Med Imaging. 2024; 24(1):310.
PMID: 39548404
PMC: 11568675.
DOI: 10.1186/s12880-024-01492-1.
Yamanaka Y, Ota T, Masuoka Y, Takeyasu Y, Nakamura S, Terashima M
Cancers (Basel). 2024; 16(18).
PMID: 39335099
PMC: 11430718.
DOI: 10.3390/cancers16183127.
Synthesis, cytotoxicity and Tc-MIBI tumor cell uptake evaluation of 2-phenylbenzothiazole tagged triazole derivatives.
Aghaei Khouzani M, Noaparast Z, Asadi T, Saeidi S, Heidarnia A, Hamzeh Moghadam B
Future Med Chem. 2024; 16(19):1999-2012.
PMID: 39229781
PMC: 11485743.
DOI: 10.1080/17568919.2024.2389771.
Radiotherapy and immunology.
Wang L, Lynch C, Pitroda S, Piffko A, Yang K, Huser A
J Exp Med. 2024; 221(7).
PMID: 38771260
PMC: 11110906.
DOI: 10.1084/jem.20232101.
Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance.
Bugno J, Wang L, Yu X, Cao X, Wang J, Huang X
Clin Cancer Res. 2024; 30(19):4450-4463.
PMID: 38691100
PMC: 11444901.
DOI: 10.1158/1078-0432.CCR-23-3616.
An AI-based approach for modeling the synergy between radiotherapy and immunotherapy.
Peng H, Moore C, Zhang Y, Saha D, Jiang S, Timmerman R
Sci Rep. 2024; 14(1):8250.
PMID: 38589494
PMC: 11001871.
DOI: 10.1038/s41598-024-58684-6.
Efficacy of combined tumor irradiation and K3.1-targeting with TRAM-34 in a syngeneic glioma mouse model.
Stransky N, Ganser K, Quintanilla-Martinez L, Gonzalez-Menendez I, Naumann U, Eckert F
Sci Rep. 2023; 13(1):20604.
PMID: 37996600
PMC: 10667541.
DOI: 10.1038/s41598-023-47552-4.
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol.
Modesto A, Tougeron D, Tremolieres P, Ronchin P, Jouve A, Leignel D
BMC Cancer. 2023; 23(1):966.
PMID: 37828434
PMC: 10568784.
DOI: 10.1186/s12885-023-11227-0.
Activation of STING in Response to Partial-Tumor Radiation Exposure.
Mathieu M, Budhu S, Nepali P, Russell J, Powell S, Humm J
Int J Radiat Oncol Biol Phys. 2023; 117(4):955-965.
PMID: 37244631
PMC: 11334988.
DOI: 10.1016/j.ijrobp.2023.05.032.
Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity.
Gao Z, Zhao Q, Xu Y, Wang L
Radiat Oncol. 2023; 18(1):89.
PMID: 37226275
PMC: 10207801.
DOI: 10.1186/s13014-023-02278-5.
Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
Santos P, Li X, Gomez D
Cancers (Basel). 2022; 14(16).
PMID: 36010969
PMC: 9406686.
DOI: 10.3390/cancers14163977.
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy.
Wang H, Ji D, Tian H, Gao Z, Song C, Jia J
BMC Cancer. 2022; 22(1):868.
PMID: 35945555
PMC: 9361520.
DOI: 10.1186/s12885-022-09960-z.
Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives.
Candiota A, Arus C
Metabolites. 2022; 12(3).
PMID: 35323686
PMC: 8950145.
DOI: 10.3390/metabo12030243.
Modern evidence and future prospects of external body radiation therapy for lung oligometastases of breast cancer.
Wada Y, Hashimoto M
Transl Cancer Res. 2022; 9(8):5077-5086.
PMID: 35117873
PMC: 8799217.
DOI: 10.21037/tcr.2020.02.55.
Immunomodulatory features of radiotherapy in lung carcinoma.
Shen G, Wang W, Da Y, Li D, Bai L, Tai J
Transl Cancer Res. 2022; 9(1):42-48.
PMID: 35117156
PMC: 8797673.
DOI: 10.21037/tcr.2019.11.07.
Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways.
Wang H, Pan J, Barsky L, Jacob J, Zheng Y, Gao C
Mol Biomed. 2022; 2(1):3.
PMID: 35006432
PMC: 8607426.
DOI: 10.1186/s43556-020-00022-z.
Radiation-activated secretory proteins of club cells increase the efficacy of immune checkpoint blockade in lung cancer.
Ban Y, Markowitz G, Zou Y, Ramchandani D, Kraynak J, Sheng J
Nat Cancer. 2021; 2(9):919-931.
PMID: 34917944
PMC: 8670735.
DOI: 10.1038/s43018-021-00245-1.